Japan Clinical Oncology NGS Market (2025-2031) | Share, Size & Revenue, Competitive Landscape, Outlook, Value, Trends, Companies, Analysis, Industry, Forecast, Growth, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan Clinical Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Japan Clinical Oncology NGS Market - Industry Life Cycle

3.4 Japan Clinical Oncology NGS Market - Porter's Five Forces

3.5 Japan Clinical Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Japan Clinical Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.7 Japan Clinical Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 Japan Clinical Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of cancer in Japan

4.2.2 Growing adoption of Next-Generation Sequencing (NGS) technology in oncology

4.2.3 Technological advancements in clinical oncology NGS

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for clinical oncology NGS in Japan

4.3.2 High cost associated with NGS technology implementation

4.3.3 Data privacy and security concerns in genomic data handling

6.1 Japan Clinical Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Japan Clinical Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Japan Clinical Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Japan Clinical Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.1.5 Japan Clinical Oncology NGS Market Revenues & Volume, By Targeted Sequencing & Resequencing Centrifuges, 2021- 2031F

6.2 Japan Clinical Oncology NGS Market, By Workflow

6.2.1 Overview and Analysis

6.2.2 Japan Clinical Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.2.3 Japan Clinical Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.2.4 Japan Clinical Oncology NGS Market Revenues & Volume, By Data Analysis, 2021- 2031F

6.3 Japan Clinical Oncology NGS Market, By Application

6.3.1 Overview and Analysis

6.3.2 Japan Clinical Oncology NGS Market Revenues & Volume, By Screening, 2021- 2031F

6.3.3 Japan Clinical Oncology NGS Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F

6.3.4 Japan Clinical Oncology NGS Market Revenues & Volume, By Other Diagnostics, 2021- 2031F

6.4 Japan Clinical Oncology NGS Market, By End-use

6.4.1 Overview and Analysis

6.4.2 Japan Clinical Oncology NGS Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Japan Clinical Oncology NGS Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Japan Clinical Oncology NGS Market Revenues & Volume, By Laboratories, 2021- 2031F

7.1 Japan Clinical Oncology NGS Market Export to Major Countries

7.2 Japan Clinical Oncology NGS Market Imports from Major Countries

8.1 Average turnaround time for NGS testing in clinical oncology

8.2 Rate of adoption of NGS technology in oncology clinics and hospitals

8.3 Number of research collaborations and partnerships in the field of clinical oncology NGS

8.4 Frequency of updates and advancements in NGS technology specific to oncology applications

8.5 Patient satisfaction scores related to the accuracy and effectiveness of NGS testing in clinical oncology

9.1 Japan Clinical Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Japan Clinical Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.3 Japan Clinical Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.4 Japan Clinical Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Japan Clinical Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Japan Clinical Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters